Annual EBITDA:
-$3.76B-$473.00M(-14.41%)Summary
- As of today, MRNA annual EBITDA is -$3.76 billion, with the most recent change of -$473.00 million (-14.41%) on December 31, 2024.
- During the last 3 years, MRNA annual EBITDA has fallen by -$17.28 billion (-127.76%).
- MRNA annual EBITDA is now -127.76% below its all-time high of $13.53 billion, reached on December 31, 2021.
Performance
MRNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$208.00M+$642.00M(+75.53%)Summary
- As of today, MRNA quarterly EBITDA is -$208.00 million, with the most recent change of +$642.00 million (+75.53%) on September 30, 2025.
- Over the past year, MRNA quarterly EBITDA has dropped by -$190.00 million (-1055.56%).
- MRNA quarterly EBITDA is now -103.84% below its all-time high of $5.42 billion, reached on December 31, 2021.
Performance
MRNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$3.25B-$190.00M(-6.20%)Summary
- As of today, MRNA TTM EBITDA is -$3.25 billion, with the most recent change of -$190.00 million (-6.20%) on September 30, 2025.
- Over the past year, MRNA TTM EBITDA has dropped by -$885.00 million (-37.34%).
- MRNA TTM EBITDA is now -119.76% below its all-time high of $16.47 billion, reached on March 31, 2022.
Performance
MRNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MRNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -14.4% | -1055.6% | -37.3% |
| 3Y3 Years | -127.8% | -116.9% | -124.2% |
| 5Y5 Years | -629.3% | +8.2% | -455.3% |
MRNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -127.8% | at low | -113.0% | +88.3% | -124.2% | +28.8% |
| 5Y | 5-Year | -127.8% | at low | -103.8% | +88.3% | -119.8% | +28.8% |
| All-Time | All-Time | -127.8% | at low | -103.8% | +88.3% | -119.8% | +28.8% |
MRNA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$208.00M(+75.5%) | -$3.25B(-6.2%) |
| Jun 2025 | - | -$850.00M(+15.9%) | -$3.06B(+13.3%) |
| Mar 2025 | - | -$1.01B(+14.8%) | -$3.54B(+5.8%) |
| Dec 2024 | -$3.76B(-14.4%) | -$1.19B(-6488.9%) | -$3.76B(-58.5%) |
| Sep 2024 | - | -$18.00M(+98.6%) | -$2.37B(+42.4%) |
| Jun 2024 | - | -$1.32B(-7.5%) | -$4.12B(+10.0%) |
| Mar 2024 | - | -$1.23B(-715.0%) | -$4.57B(-26.2%) |
| Dec 2023 | -$3.28B(-133.0%) | $200.00M(+111.3%) | -$3.62B(-63.1%) |
| Sep 2023 | - | -$1.76B(+0.8%) | -$2.22B(-387.6%) |
| Jun 2023 | - | -$1.78B(-534.6%) | $772.00M(-84.7%) |
| Mar 2023 | - | -$280.00M(-117.5%) | $5.04B(-47.6%) |
| Dec 2022 | $9.95B(-26.4%) | $1.60B(+30.2%) | $9.61B(-28.4%) |
| Sep 2022 | - | $1.23B(-50.7%) | $13.43B(-15.2%) |
| Jun 2022 | - | $2.49B(-41.9%) | $15.83B(-3.9%) |
| Mar 2022 | - | $4.29B(-20.8%) | $16.47B(+22.4%) |
| Dec 2021 | $13.53B(+1948.1%) | $5.42B(+49.4%) | $13.46B(+73.2%) |
| Sep 2021 | - | $3.63B(+15.9%) | $7.77B(+98.4%) |
| Jun 2021 | - | $3.13B(+144.4%) | $3.92B(+482.6%) |
| Mar 2021 | - | $1.28B(+579.2%) | $672.52M(+191.9%) |
| Dec 2020 | -$732.00M(-42.1%) | -$267.33M(-18.0%) | -$731.89M(-24.9%) |
| Sep 2020 | - | -$226.62M(-97.9%) | -$586.17M(-21.4%) |
| Jun 2020 | - | -$114.53M(+7.2%) | -$483.02M(+4.3%) |
| Mar 2020 | - | -$123.41M(-1.5%) | -$504.70M(+2.1%) |
| Dec 2019 | -$515.00M(-44.5%) | -$121.62M(+1.5%) | -$515.62M(+4.5%) |
| Sep 2019 | - | -$123.46M(+9.4%) | -$539.68M(-8.9%) |
| Jun 2019 | - | -$136.21M(-1.4%) | -$495.55M(-10.0%) |
| Mar 2019 | - | -$134.32M(+7.8%) | -$450.48M(-16.0%) |
| Dec 2018 | -$356.45M(-51.5%) | -$145.68M(-83.6%) | -$388.40M(-39.4%) |
| Sep 2018 | - | -$79.34M(+12.9%) | -$278.64M(-6.3%) |
| Jun 2018 | - | -$91.14M(-26.1%) | -$262.04M(-52.4%) |
| Mar 2018 | - | -$72.25M(-101.2%) | -$171.95M(-70.8%) |
| Dec 2017 | -$235.33M(-12.8%) | -$35.91M(+42.8%) | -$100.67M(-54.4%) |
| Sep 2017 | - | -$62.74M(-5879.2%) | -$65.20M(-2444.9%) |
| Jun 2017 | - | -$1.05M(-8.0%) | -$2.56M(-56.1%) |
| Mar 2017 | - | -$971.90K(-119.2%) | -$1.64M(-109.5%) |
| Dec 2016 | -$208.66M(-6351.0%) | - | - |
| Dec 2016 | - | -$443.30K(-353.7%) | -$783.60K(-112.3%) |
| Sep 2016 | - | -$97.70K(+23.9%) | $6.37M(+17.2%) |
| Jun 2016 | - | -$128.40K(-12.4%) | $5.43M(+19.7%) |
| Mar 2016 | - | -$114.20K(-101.7%) | $4.54M(+36.0%) |
| Dec 2015 | $3.34M(+161.0%) | $6.71M(+749.9%) | $3.34M(+37.2%) |
| Sep 2015 | - | -$1.03M(-1.0%) | $2.43M(+166.5%) |
| Jun 2015 | - | -$1.02M(+22.3%) | -$3.66M(-384.7%) |
| Mar 2015 | - | -$1.31M(-122.7%) | $1.28M(+123.5%) |
| Dec 2014 | -$5.47M(-302.0%) | $5.80M(+181.5%) | -$5.47M(+58.6%) |
| Sep 2014 | - | -$7.12M(-281.7%) | -$13.21M(-88.7%) |
| Jun 2014 | - | $3.92M(+148.6%) | -$7.00M(+37.0%) |
| Mar 2014 | - | -$8.07M(-316.0%) | -$11.11M(-593.0%) |
| Dec 2013 | -$1.36M(+81.2%) | -$1.94M(-112.7%) | -$1.60M(+63.8%) |
| Sep 2013 | - | -$912.00K(-390.3%) | -$4.43M(+9.7%) |
| Jun 2013 | - | -$186.00K(-113.0%) | -$4.90M(-131.4%) |
| Mar 2013 | - | $1.44M(+130.1%) | -$2.12M(+70.7%) |
| Dec 2012 | -$7.24M(+73.2%) | -$4.76M(-242.9%) | -$7.24M(+61.7%) |
| Sep 2012 | - | -$1.39M(-153.5%) | -$18.87M(+12.5%) |
| Jun 2012 | - | $2.60M(+170.6%) | -$21.57M(+26.2%) |
| Mar 2012 | - | -$3.68M(+77.5%) | -$29.21M(+3.3%) |
| Dec 2011 | -$27.03M(-15.8%) | -$16.40M(-301.3%) | -$30.21M(-66.8%) |
| Sep 2011 | - | -$4.09M(+19.1%) | -$18.11M(+16.3%) |
| Jun 2011 | - | -$5.05M(-7.9%) | -$21.63M(-9.5%) |
| Mar 2011 | - | -$4.68M(-8.7%) | -$19.75M(+4.2%) |
| Dec 2010 | -$23.35M(-196.7%) | -$4.30M(+43.4%) | -$20.61M(-7.8%) |
| Sep 2010 | - | -$7.61M(-140.2%) | -$19.12M(-6.4%) |
| Jun 2010 | - | -$3.17M(+42.8%) | -$17.96M(+16.6%) |
| Mar 2010 | - | -$5.54M(-97.2%) | -$21.55M(-192.6%) |
| Dec 2009 | -$7.87M | -$2.81M(+56.5%) | -$7.37M(+53.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$6.45M(+4.4%) | -$15.87M(+12.7%) |
| Jun 2009 | - | -$6.75M(-178.1%) | -$18.18M(+25.6%) |
| Mar 2009 | - | $8.65M(+176.5%) | -$24.44M(+47.5%) |
| Dec 2008 | -$46.57M(+7.1%) | -$11.31M(-29.0%) | -$46.57M(-0.3%) |
| Sep 2008 | - | -$8.77M(+32.6%) | -$46.42M(+13.2%) |
| Jun 2008 | - | -$13.01M(+3.5%) | -$53.48M(-2.1%) |
| Mar 2008 | - | -$13.48M(-20.8%) | -$52.40M(-4.5%) |
| Dec 2007 | -$50.14M(-89.8%) | -$11.16M(+29.4%) | -$50.14M(-2.1%) |
| Sep 2007 | - | -$15.82M(-32.5%) | -$49.13M(-19.9%) |
| Jun 2007 | - | -$11.94M(-6.4%) | -$40.96M(-38.6%) |
| Mar 2007 | - | -$11.22M(-10.5%) | -$29.55M(-11.9%) |
| Dec 2006 | -$26.41M(+17.4%) | -$10.15M(-32.7%) | -$26.41M(-4.8%) |
| Sep 2006 | - | -$7.65M(-1354.6%) | -$25.20M(+4.3%) |
| Jun 2006 | - | -$526.00K(+93.5%) | -$26.33M(+22.7%) |
| Mar 2006 | - | -$8.09M(+9.6%) | -$34.06M(-6.6%) |
| Dec 2005 | -$31.97M(-18.2%) | -$8.94M(-1.8%) | -$31.97M(-11.8%) |
| Sep 2005 | - | -$8.78M(-6.3%) | -$28.59M(-6.0%) |
| Jun 2005 | - | -$8.26M(-37.8%) | -$26.98M(-4.9%) |
| Mar 2005 | - | -$5.99M(-7.7%) | -$25.71M(+4.9%) |
| Dec 2004 | -$27.05M(-463.9%) | -$5.56M(+22.4%) | -$27.05M(+0.5%) |
| Sep 2004 | - | -$7.17M(-2.5%) | -$27.19M(-4.6%) |
| Jun 2004 | - | -$6.99M(+4.5%) | -$25.99M(-166.3%) |
| Mar 2004 | - | -$7.32M(-28.5%) | -$9.76M(-103.5%) |
| Dec 2003 | -$4.80M(+58.6%) | -$5.70M(+4.7%) | -$4.80M(-30.6%) |
| Sep 2003 | - | -$5.98M(-164.7%) | -$3.67M(-356.7%) |
| Jun 2003 | - | $9.24M(+491.6%) | -$804.00K(+92.9%) |
| Mar 2003 | - | -$2.36M(+48.4%) | -$11.26M(+2.8%) |
| Dec 2002 | -$11.59M(-33.1%) | -$4.57M(-47.1%) | -$11.59M(-17.1%) |
| Sep 2002 | - | -$3.11M(-155.3%) | -$9.89M(-16.9%) |
| Jun 2002 | - | -$1.22M(+54.7%) | -$8.46M(+8.0%) |
| Mar 2002 | - | -$2.69M(+6.8%) | -$9.20M(-5.7%) |
| Dec 2001 | -$8.71M(+9.3%) | -$2.88M(-71.5%) | -$8.71M(+6.8%) |
| Sep 2001 | - | -$1.68M(+13.9%) | -$9.34M(-0.3%) |
| Jun 2001 | - | -$1.95M(+10.9%) | -$9.31M(+2.9%) |
| Mar 2001 | - | -$2.19M(+37.7%) | -$9.60M(+0.1%) |
| Dec 2000 | -$9.60M(-6.1%) | -$3.52M(-112.8%) | -$9.60M(+3.4%) |
| Sep 2000 | - | -$1.65M(+26.0%) | -$9.94M(+2.1%) |
| Jun 2000 | - | -$2.23M(-1.6%) | -$10.15M(-6.7%) |
| Mar 2000 | - | -$2.20M(+43.0%) | -$9.51M(+1.1%) |
| Dec 1999 | -$9.05M(-341.2%) | -$3.85M(-106.9%) | -$9.62M(-18.5%) |
| Sep 1999 | - | -$1.86M(-16.4%) | -$8.11M(-25.8%) |
| Jun 1999 | - | -$1.60M(+30.4%) | -$6.45M(-27.7%) |
| Mar 1999 | - | -$2.30M(+2.2%) | -$5.05M(-77.1%) |
| Dec 1998 | -$2.05M(+64.0%) | -$2.35M(-1076.0%) | -$2.85M(-1.9%) |
| Sep 1998 | - | -$200.00K(0.0%) | -$2.80M(+33.3%) |
| Jun 1998 | - | -$200.00K(-100.0%) | -$4.20M(+20.8%) |
| Mar 1998 | - | -$100.00K(+95.7%) | -$5.30M(+10.2%) |
| Dec 1997 | -$5.70M(-1040.0%) | -$2.30M(-43.8%) | -$5.90M(-63.9%) |
| Sep 1997 | - | -$1.60M(-23.1%) | -$3.60M(-80.0%) |
| Jun 1997 | - | -$1.30M(-85.7%) | -$2.00M(-300.0%) |
| Mar 1997 | - | -$700.00K(>-9900.0%) | -$500.00K(>-9900.0%) |
| Dec 1996 | -$500.00K(>-9900.0%) | - | - |
| Sep 1996 | - | $0.00(-100.0%) | $0.00(+100.0%) |
| Jun 1996 | $0.00(+100.0%) | $200.00K(+100.0%) | -$100.00K(+66.7%) |
| Mar 1996 | - | $100.00K(+133.3%) | -$300.00K(+25.0%) |
| Dec 1995 | - | -$300.00K(-200.0%) | -$400.00K(-100.0%) |
| Sep 1995 | - | -$100.00K(>-9900.0%) | -$200.00K(>-9900.0%) |
| Jun 1995 | -$100.00K(-150.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1995 | - | $0.00(+100.0%) | $100.00K(>+9900.0%) |
| Dec 1994 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
| Sep 1994 | - | $100.00K(0.0%) | $200.00K(0.0%) |
| Jun 1994 | $200.00K | $100.00K(+200.0%) | $200.00K(+100.0%) |
| Mar 1994 | - | -$100.00K(-200.0%) | $100.00K(-50.0%) |
| Dec 1993 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Moderna, Inc.?
- What is Moderna, Inc. annual EBITDA year-on-year change?
- What is Moderna, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Moderna, Inc.?
- What is Moderna, Inc. quarterly EBITDA year-on-year change?
- What is Moderna, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Moderna, Inc.?
- What is Moderna, Inc. TTM EBITDA year-on-year change?
What is Moderna, Inc. annual EBITDA?
The current annual EBITDA of MRNA is -$3.76B
What is the all-time high annual EBITDA for Moderna, Inc.?
Moderna, Inc. all-time high annual EBITDA is $13.53B
What is Moderna, Inc. annual EBITDA year-on-year change?
Over the past year, MRNA annual EBITDA has changed by -$473.00M (-14.41%)
What is Moderna, Inc. quarterly EBITDA?
The current quarterly EBITDA of MRNA is -$208.00M
What is the all-time high quarterly EBITDA for Moderna, Inc.?
Moderna, Inc. all-time high quarterly EBITDA is $5.42B
What is Moderna, Inc. quarterly EBITDA year-on-year change?
Over the past year, MRNA quarterly EBITDA has changed by -$190.00M (-1055.56%)
What is Moderna, Inc. TTM EBITDA?
The current TTM EBITDA of MRNA is -$3.25B
What is the all-time high TTM EBITDA for Moderna, Inc.?
Moderna, Inc. all-time high TTM EBITDA is $16.47B
What is Moderna, Inc. TTM EBITDA year-on-year change?
Over the past year, MRNA TTM EBITDA has changed by -$885.00M (-37.34%)